glp-1 really work Drugs Show Promise, But Researchers Question Lifelong Use, Prescriptions for Children, and Cost Barriers We need to talk about

Patients received arGLP-1 based on availability and clinical appropriateness: semaglutide was administered via weekly subcutaneous injections, starting at 0.25 mg/week and titrated to a maximum dose of 1 mg/week, while dulaglutide was administered at a fixed dose of 1.5 mg/week

Their continuous investment in research and development, particularly in oral formulations and novel indications, further strengthens their position

Ive used them myself. But for years, he explained, lots of peptide devotees had been getting the injectable vials from a legally gray marketplace that sells peptides for lab use only

Saxenda was the first to be approved in 2014, followed by Wegovy in 2020 and Zepbound in 2023